Trial Profile
A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic low back pain
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 14 Mar 2016 New trial record